ERBB2 and breast carcinoma: Since DNA-level epigenetic regulation (promoter CpG island methylation) has no role in the expression of ERBB2, we hypothesized that chromatin remodeling may control ERBB2 expression in the epithelial-like and mesenchymal-like breast cancer cells.